In the News
SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout
New users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had about half the risk of an ED visit or hospitalization for a gout flare as matched patients taking dipeptidyl peptidase-4 inhibitors, a cohort analysis found.
Phase 3 trial shows efficacy of donanemab for Alzheimer disease
In an industry-funded, placebo-controlled trial of patients with early symptomatic Alzheimer disease and amyloid and tau pathology, patients on the investigational drug donanemab showed significant slowing in worsening on the integrated Alzheimer Disease Rating Scale score.
MKSAP Quiz: Evaluation of an incidentally found aneurysm
A 31-year-old man is evaluated for a 5-mm saccular aneurysm in the anterior communicating artery found incidentally on a magnetic resonance angiogram of the head. Following a physical and neurological examination, what is the most appropriate management?
Long-term doxycycline may reduce exacerbations for some COPD patients
A randomized trial in the U.K. found that 12 months of doxycycline did not improve chronic obstructive pulmonary disease (COPD) exacerbations overall versus placebo but may have reduced rates in patients with severe disease or lower blood eosinophil counts.
New ACP paper calls for preparation for future public health emergencies
ACP calls for a federal pandemic preparedness plan that is adequately funded and prioritizes health equity in a new position paper published in Annals of Internal Medicine.
ACP joins internal medicine organizations in awarding grants to support DEI
A total of $470,000 in grants was awarded to 20 projects promoting diversity, equity, and inclusion (DEI) at medical schools and teaching hospitals across the U.S.
And the winner is …
ACP Internist Weekly has tallied the voting from its latest cartoon contest, where readers are invited to match wits against their peers to provide the most original and amusing caption.